logo

For the Inventor, By the Inventor

Copenhagen, Denmark

Veloxis Pharmaceuticals A/s

Calculating rank
USPTO Granted Patents = 24

% Expired Patents = 25.0



Trademarks = 2

Forward Citations = 143

Loading Chart...
Loading Chart...

11 inventors (with patents filed for the assignee):

goldMedal Per Holm (22 out of 36 patents)

silverMedal Tomas Norling (14 out of 22 patents)

bronzeMedal Robert D Gordon (3 out of 15 patents)

4.  Anne-Marie Lademann (3 out of 6 patents)

5.  William J Polvino (2 out of 15 patents)

6.  Nikolaj Skak (2 out of 11 patents)

7.  Anders Burr (2 out of 2 patents)

8.  Michiel Ringkjøbing-elema (2 out of 2 patents)

9.  Jannie Egeskov Holm (2 out of 3 patents)

10.  Birgitte Møllgaard (2 out of 3 patents)

11.  Kirsten Schultz (2 out of 3 patents)

12.  Anne-Marie Lademann (4 patents)

13.  Anders Buur (3 patents)

14.  Michiel Onne Elema (1 patent)

15.  Birgitte Mollgaard (2 patents)


24 patents:

1. 10864199 - Tacrolimus for improved treatment of transplant patients (2020-12-15),
2. 10548880 - Solid dispersions comprising tacrolimus (2020-02-04),
3. 10485793 - Regimen for suppressing organ rejection (2019-11-26),
4. 10166190 - Stabilized tacrolimus composition (2019-01-01),
5. 9775834 - Regimen for supressing organ rejection (2017-10-03),
6. 9763920 - Solid dispersions comprising tacrolimus (2017-09-19),
7. 9757362 - Modified release compositions comprising tacrolimus (2017-09-12),
8. 9549918 - Stabilized tacrolimus composition (2017-01-24),
9. 9295653 - Controlled agglomeration (2016-03-29),
10. 9173847 - Tablet comprising a fibrate (2015-11-03),
11. 9161907 - Modified release compositions comprising tacrolimus (2015-10-20),
12. 8889186 - Modified release compositions comprising tacrolimus (2014-11-18),
13. 8889185 - Modified release compositions comprising tacrolimus (2014-11-18),
14. 8685998 - Tacrolimus for improved treatment of transplant patients (2014-04-01),
15. 8664239 - Tacrolimus for improved treatment of transplant patients (2014-03-04),
Company Overview
Veloxis Pharmaceuticals A/S is a biotechnology company based in Copenhagen, Denmark, specializing in the development of innovative therapies for transplant patients. The company focuses on enhancing the safety and efficacy of immunosuppressive treatments, aiming to improve patient outcomes and quality of life. Veloxis leverages advanced research in pharmacology and drug formulation to create solutions that address unmet medical needs in the field of organ transplantation.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

Veloxis Pharmaceuticals A/s USPTO Patent Assignee Logo
24 Patents

#17 in Copenhagen

#121 in Denmark

#26,701 in the World

Copenhagen, DK
Copenhagen, Denmark

Veloxis Pharmaceuticals A/s

Forward Citations = 143

11 inventors:

goldMedal Per Holm (22 out of 36 patents)

silverMedal Tomas Norling (14 out of 22 patents)

bronzeMedal Robert D Gordon (3 out of 15 patents)

4.  Anne-Marie Lademann (3 out of 6 patents)

5.  William J Polvino (2 out of 15 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Veloxis Pharmaceuticals A/s. Retrieved from https://idiyas.com/company/veloxis-pharmaceuticals-a-s

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…